Lead on development and execution of Medicare coverage, coding, and reimbursement strategy. Point person for advocacy and external partners regarding inflammatory bowel disease.

·Secured coverage and created positive reimbursement within Medicare and Medicaid programs for newly-launched, premium-priced IV iron therapy in the following states: OH, WV, PA, MD, DC, DE, NJ, NY, CT, RI, MA, VT, NH, ME.·Provided strategic reimbursement input to AMAG upper management and sales representatives in region that prepared them for successful and efficient sales planning and objection handling.·Interacted with, partnered, and educated Medical Directors and policy analysts at 4 Medicare Administrative Contractors and Medical Directors and pharmacy staff in each Medicaid program to achieve initial, continuing, and unrestricted reimbursement for product.·Established relationships with dialysis clinics, nephrology clinics, hematology/oncology practice staffs, and key physicians that supported sales and contributed to complex reimbursement issue resolution.·Helped secure a Q code for product six months from launch to enable reliable reimbursement and furthering sales in crowded IV iron therapy drug class.·Assisted in creation of gold standard reimbursement hotline; trained counselors; and collaborated with team to resolve government payer claims’ adjudication errors and provider claims’ filing errors.·Conducted outreach to professional and patient groups and garnered grassroots support for coverage initiatives and inclusion of product information in 3 Medicare articles and physician group newsletters.·Attended national conferences on behalf of AMAG (NRAA, RPA, NKF) to obtain contacts, garner information, and answer reimbursement questions.·Received Outstanding Achievement Award for 2009 (one of only six in company).

·Researched and analyzed legislative and regulatory proposals and their potential impact on TAP/Takeda’s business interests to aid in corporate business strategy development.·Advocated company positions to members of Congress, relevant government agencies, advocacy groups, and trade associations to protect corporate objectives.·Educated Takeda/TAP personnel about current and future actions by Congress and federal agencies that could impact Takeda/TAP's marketplace or operations to aid in business planning.·Provided regular presentations to the President and his executive staff to insure full understanding of public policy implications on product accessibility and development in advance of decision-making.·Coordinated communication and developed talking points for use with all issue stakeholders to influence federal agencies' policies and congressional actions.·Represented Takeda/TAP at PhRMA policy workgroups and other forums to obtain critical intelligence regarding state and federal policy initiatives and industry responses.·Developed new advocacy partners and garnered grassroots support.·Specialized in FDA-related legislation and regulations and on Medicare Parts B and D.

·Represented and protected TAP’s business interests in the legislatures and executive branches of 6 states (PA, NJ, DE, DC, MD, WV) and before Medicare Part B carriers.·Lobbied and advocated as necessary.·Briefed upper management on issues with impact to TAP and recommended strategies and changes as appropriate.·Developed close working relationships with elected officials, legislative staff, executive branch officials, and Part B carrier policy staff; collaborated with pharmaceutical colleagues and industry trade association; and partnered with professional organizations and patient advocacy groups.·Supported corporate goals by frequently communicating coverage and reimbursement developments with sales management and representatives.·Maximized TAP product access during preferred drug list implementations by focusing heavily on Medicaid programs from 2001-2005.·Specialized in federal affairs which required analysis, reporting, and frequent contact with President, Executive Vice-President, and others in upper management.·Received Capitol Achievement Award for 2003 and 2005.

·Managed overall operation of active congressional office with primary emphasis on Washington activities.·Hired and directed administrative and legislative staff.·Oversaw office budget and finances, scheduled, and supervised press operation.·Insured Member and staff compliance with House ethics rules.·Resolved and managed unique constituent concerns and projects.·Advised Member on a broad array of health care issues.·Oversaw passage of immunosuppressive drug coverage legislation in major Medicare bill.·Wrote and/or edited all official documents including letters, speeches, press releases, and other official communications.